WHO update (10 Mar) – including 2 possible, small human-human-transmission clusters and a Hong Kong case after a visit to mainland China.
Outbreak News Today update (13 Mar) including ECDC map and risk assessment of HPAI mutants
ECDC 6th Rapid Risk Assessment on H7N9 in China (9 Mar)
New Scientist article (21 Feb) on increased number of human H7N9 cases in China this year, with emergence of HPAI derivatives in China & Taiwan
Laurie Garrett’s article (“A Lethal Bird Flu Returns to China“) on H7N9 in China on the Council on Foreign Relations website.
Avian Influenza in humans, H7N9 Factsheet for Health Professionals & Avian Influenza in Humans Risk Assessments (ECDC)
Blogs: Avian Flu Diary Crawford Kilian’s H7N9
Highly Pathogenic Avian Influenza A(H5N8) Virus in Wild Migratory Birds, Qinghai Lake, China
Li M, Liu H, Bi Y, Sun J, Wong G, Liu D et al. (2017). Emerg Infect Dis. Apr [cited 10-Feb-2017]. http://dx.doi.org/10.3201/eid2304.161866
Industry and public-health experts concerned about ramifications of Nagoya Protocol.
Report by Daniel Cressey in Nature, 9 February 2017, with comments by:
John McCauley, director of the Francis Crick Institute Worldwide Influenza Centre in London
Stephen Inglis, former director of the UK’s National Institute for Biological Standards and Control (the Institute’s Influenza Resource Centre play’s important roles in the development of new seasonal and pre-pandemic influenza vaccines)